173 related articles for article (PubMed ID: 20082578)
1. Identification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.
Oleson L; von Moltke LL; Greenblatt DJ; Court MH
Xenobiotica; 2010 Feb; 40(2):146-62. PubMed ID: 20082578
[TBL] [Abstract][Full Text] [Related]
2. Human pregnane X receptor: genetic polymorphisms, alternative mRNA splice variants, and cytochrome P450 3A metabolic activity.
He P; Court MH; Greenblatt DJ; von Moltke LL
J Clin Pharmacol; 2006 Nov; 46(11):1356-69. PubMed ID: 17050801
[TBL] [Abstract][Full Text] [Related]
3. MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.
Lamba J; Strom S; Venkataramanan R; Thummel KE; Lin YS; Liu W; Cheng C; Lamba V; Watkins PB; Schuetz E
Clin Pharmacol Ther; 2006 Apr; 79(4):325-38. PubMed ID: 16580901
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers.
Oliver P; Lubomirov R; Carcas A
Clin Chem Lab Med; 2010 May; 48(5):635-9. PubMed ID: 20218903
[TBL] [Abstract][Full Text] [Related]
5. Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression.
Lamba J; Lamba V; Strom S; Venkataramanan R; Schuetz E
Drug Metab Dispos; 2008 Jan; 36(1):169-81. PubMed ID: 17925385
[TBL] [Abstract][Full Text] [Related]
6. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.
Zhang J; Kuehl P; Green ED; Touchman JW; Watkins PB; Daly A; Hall SD; Maurel P; Relling M; Brimer C; Yasuda K; Wrighton SA; Hancock M; Kim RB; Strom S; Thummel K; Russell CG; Hudson JR; Schuetz EG; Boguski MS
Pharmacogenetics; 2001 Oct; 11(7):555-72. PubMed ID: 11668216
[TBL] [Abstract][Full Text] [Related]
7. PXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisinin.
Piedade R; Schaeffeler E; Winter S; Asimus S; Schwab M; Ashton M; Burk O; Gil JP
Antimicrob Agents Chemother; 2012 Apr; 56(4):2153-7. PubMed ID: 22252826
[TBL] [Abstract][Full Text] [Related]
8. PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients.
Sandanaraj E; Lal S; Selvarajan V; Ooi LL; Wong ZW; Wong NS; Ang PC; Lee EJ; Chowbay B
Clin Cancer Res; 2008 Nov; 14(21):7116-26. PubMed ID: 18981011
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivo.
He P; Court MH; Greenblatt DJ; Von Moltke LL
Clin Pharmacol Ther; 2005 May; 77(5):373-87. PubMed ID: 15900284
[TBL] [Abstract][Full Text] [Related]
10. Rat PXR reporter-gene activity correlates with the induction of CYP3A in rat precision-cut liver slices.
Cui X; Thomas A; Montgomery D; Gu C; Morrison RA; White RE; Cheng KC
Comb Chem High Throughput Screen; 2005 Jun; 8(4):341-6. PubMed ID: 16101010
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics.
Tham LS; Holford NH; Hor SY; Tan T; Wang L; Lim RC; Lee HS; Lee SC; Goh BC
Clin Cancer Res; 2007 Dec; 13(23):7126-32. PubMed ID: 18056193
[TBL] [Abstract][Full Text] [Related]
12. Association of genotypes of the CYP3A cluster with midazolam disposition in vivo.
Miao J; Jin Y; Marunde RL; Gorski CJ; Kim S; Quinney S; Radovich M; Li L; Hall SD
Pharmacogenomics J; 2009 Oct; 9(5):319-26. PubMed ID: 19506580
[TBL] [Abstract][Full Text] [Related]
13. Screening for the 3'UTR Polymorphism of the PXR Gene in South Indian Breast Cancer Patients and its Potential Role in Pharmacogenomics.
Revathidevi S; Sudesh R; Vaishnavi V; Kaliyanasundaram M; MaryHelen KG; Sukanya G; Munirajan AK
Asian Pac J Cancer Prev; 2016; 17(8):3971-7. PubMed ID: 27644647
[TBL] [Abstract][Full Text] [Related]
14. Effect of Pregnane X Receptor
Yuan JJ; Ma XJ; Li ZS; Chang YZ; Zhang W; Kan QC; Hou JK; Zhang LR
BMC Med Genet; 2016 Nov; 17(1):87. PubMed ID: 27876007
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms of the pregnane x receptor gene in Han Chinese and a comparison with other ethnic populations.
Wang XD; Deng XY; Chen J; Li JL; Chen X; Zhao LZ; Lu Y; Chowbay B; Su QB; Huang M; Zhou SF
Pharmacology; 2008; 81(4):350-4. PubMed ID: 18391510
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30c-1-3p is a silencer of the pregnane X receptor by targeting the 3'-untranslated region and alters the expression of its target gene cytochrome P450 3A4.
Vachirayonstien T; Yan B
Biochim Biophys Acta; 2016 Sep; 1859(9):1238-1244. PubMed ID: 27085140
[TBL] [Abstract][Full Text] [Related]
17. Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment.
Wang JY; Tsai CH; Lee YL; Lee LN; Hsu CL; Chang HC; Chen JM; Hsu CA; Yu CJ; Yang PC
Medicine (Baltimore); 2015 Jun; 94(24):e982. PubMed ID: 26091473
[TBL] [Abstract][Full Text] [Related]
18. The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR).
Burk O; Koch I; Raucy J; Hustert E; Eichelbaum M; Brockmöller J; Zanger UM; Wojnowski L
J Biol Chem; 2004 Sep; 279(37):38379-85. PubMed ID: 15252010
[TBL] [Abstract][Full Text] [Related]
19. CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism.
Wandel C; Witte JS; Hall JM; Stein CM; Wood AJ; Wilkinson GR
Clin Pharmacol Ther; 2000 Jul; 68(1):82-91. PubMed ID: 10945319
[TBL] [Abstract][Full Text] [Related]
20. 3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition.
Antolino-Lobo I; Meulenbelt J; Nijmeijer SM; Maas-Bakker RF; Meijerman I; van den Berg M; van Duursen MB
Toxicol Lett; 2011 May; 203(1):82-91. PubMed ID: 21402137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
